Irrimax Corporation Is A Medical Device Company Located In Lawrencevillegeorgiaestablished In 2003The Company Specializes In Wound Irrigation Solutionsfocusing On Reducing Infections And Healthcare Costs While Enhancing Patient Outcomesirrimax Is Known For Its Expertise In Low Concentration Chlorhexidine Gluconate Technologywhich Is Utilized In Its Patented Products The Flagship Productirrisept Antimicrobial Wound Lavagewas Introduced In 2010 And Is Recognized As A Leader In High Performance Wound Irrigationit Provides Effective Irrigation And Infection Preventionusing Chlorhexidine Gluconate To Ensure Low Pressure Irrigation And Mechanical Cleansingover 4 000 Hospitals In The U Strust Irrisept For Their Wound Irrigation Needsirrimax Also Supports Research And Offers Clinical Evidence And Education To Its Customersemphasizing High Quality Products And Strong Customer Support In August 2024Irrimax Was Acquired By Archimeda Global Private Equity Healthcare Specialistwhich Aims To Expand The Company S Product Range And Market Reachthe Company Employs Approximately 66 People And Reported An Annual Revenue Of $4 Million As Of 2024
